Skip to main content

Table 3 Ratios significantly increased in BD patients without corticosteroid and immunosuppressant therapy compared with healthy controls and disease controls in both the discovery and validation sets

From: Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet’s disease patients receiving immunomodulatory treatment

  Discovery set BD-N vs. Validation set: BD-N vs.
HC HC AAV TA
p fc p fc p fc p fc
TP/MCV * 1.0579355 * 1.0712601 *** 1.2863344 * 1.120872
PCT/MONO ** 1.425393 * 1.5778604 * 1.6435788 * 1.5614405
TP/MCH ** 1.0904052 * 1.1113632 *** 1.2590039 * 1.0998654
TP/MCHC ** 1.0932365 ** 1.1448527 *** 1.2285696 * 1.091615
  1. * P < 0.05. ** P < 0.01. *** P < 0.001